During the initial four-week period on 0.25 mg, the medication gradually accumulates in your system until it reaches what is termed 'steady state' typically achieved after four to five weeks of consistent weekly dosing, as stated in the UK SmPC
Employer Impact Are employer-sponsored health plans required to cover GLP-1s for weight loss
Translating any of this into practice, however, requires careful attention to safety, timing, and individual variability
The troughs are higher, so appetite suppression should remain more consistent
Key Treatment Guidelines For optimal outcomes, patients should follow these essential guidelines: Maintain regular resistance training to preserve muscle mass Ensure protein intake of minimum 1.2g per kg of body weight Focus on fiber-rich nutrition protocols Prioritise stress management and sleep optimisation Long-term Considerations While microdosing presents a more conservative approach to GLP-1 therapy, several important factors require ongoing attention
Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)